
Synthecis Pharmaceuticals Private Limited
About Synthecis Pharmaceuticals Private Limited
Data last updated:
Synthecis Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2019PTC136091. Its GSTIN is 36ABCCS7669B1Z6 (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sri Vidya Vetukuri and Gande Deepthi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.07 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹60,059 (net margin 4%) and EBITDA of ₹14.7 Lakh (EBITDA margin 97.6%). Revenue has declined at a compounded annual rate (CAGR) of 56% over three years.
The company has about 6 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.8 Cr on record.
Synthecis Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0057201).
Company details
Recognitions & Rankings of Synthecis Pharmaceuticals
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TS-02-0057201
Contact details
Synthecis Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBlock B4 Flat No.301 Meadow Land Apartments Cbcid Colony Bhagathsingh Nagar Phase, 2, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Synthecis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Synthecis Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Synthecis Pharmaceuticals Private Limited, buy the company report.
Financials of Synthecis Pharmaceuticals Private Limited
FY 2025 filings availableSynthecis Pharmaceuticals Private Limited reported revenue of ₹15.07 Lakh (up 854% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 854% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 56%. EBITDA rose 619% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.7 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹60,059 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 97.6% | ||||
| Net Profit Margin | 4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Synthecis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Synthecis Pharmaceuticals Private Limited
Synthecis Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sri Vidya Vetukuri | Director | 15 Oct 2019 | 7 Years 1 Months | Current |
| Gande Deepthi | Director | 27 Oct 2021 | 5 Years 0 Months | Current |
Auditor
Synthecis Pharmaceuticals Private Limited is audited by PALOD AND LOYA CHARTERED ACCOUNTANTS for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PALOD AND LOYA CHARTERED ACCOUNTANTS | FY 2023 | 017485S |
Shareholding
The shareholding of Synthecis Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Synthecis Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Dec 2020 | 100431189 | Bank of India | ₹1.8 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Synthecis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Synthecis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Synthecis Pharmaceuticals Private Limited has a workforce of 6 employees on its EPFO records as of Oct 2021, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2021-22 | 6 |
| FY 2020-21 |
To see the full employee and EPFO history of Synthecis Pharmaceuticals Private Limited, buy the company report.
GST
Synthecis Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABCCS7669B1Z6 | Telangana | Active | 15 Nov 2019 |
To see the full GST registrations and return filing status of Synthecis Pharmaceuticals Private Limited, buy the company report.
Recent activity
Synthecis Pharmaceuticals Private Limited has 8 board changes on record since 2019: 5 appointments and 3 cessations. The latest: Venkatanaga Kali Vara Prasada Raju Vetukuri ceased to be Director on 28 Jul 2022.
Frequently asked questions
Synthecis Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 October 2019 (7+ years old) and is registered under CIN U24233TG2019PTC136091.
Synthecis Pharmaceuticals has 2 current directors:
- Sri Vidya Vetukuri - Director
- Gande Deepthi - Director
The latest financial statements of Synthecis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Synthecis Pharmaceuticals is 36ABCCS7669B1Z6, registered in Telangana.
The CIN (Corporate Identification Number) of Synthecis Pharmaceuticals is U24233TG2019PTC136091. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Synthecis Pharmaceuticals was incorporated on 15 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Venkatanaga Kali Vara Prasada Raju Vetukuri ceased to be Director on 28 Jul 2022. Gande Deepthi was appointed as Director on 27 Oct 2021. Rajesh Kumar Rapolu ceased to be Additional Director on 27 Oct 2021. Synthecis Pharmaceuticals has 8 board changes on record in total.
Yes, Synthecis Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Synthecis Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0057201).
The registered office of Synthecis Pharmaceuticals is at Block B4 Flat No.301 Meadow Land Apartments Cbcid Colony Bhagathsingh Nagar Phase, 2, Hyderabad, Telangana, India – 500072.

